THC Farmaceuticals, Inc. (CBDG)

USD 0.01

(0.0%)

Annual Income Statements

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Revenue - 10 Thousand 2234.00 7575.00 10.19 Thousand 12.2 Thousand
Cost of Revenue 4952.00 3808.00 952.00 - 2634.00 -
Gross Profit -4952.00 6192.00 1282.00 7575.00 7559.00 12.2 Thousand
Operating Expenses -25 Thousand 14.68 Thousand 19.08 Thousand 39.32 Thousand 165.65 Thousand 26.5 Thousand
Selling, General and Administrative Expenses -25 Thousand 14.68 Thousand 19.08 Thousand 39.32 Thousand 165.65 Thousand 26.5 Thousand
Research and Development Expenses - - - - - -
Other Expenses - - - - - -
Cost and Expenses 29.95 Thousand 18.49 Thousand 20.04 Thousand 40.27 Thousand 168.28 Thousand 27.45 Thousand
Operating Income -29.95 Thousand -8491.00 -17.81 Thousand -32.7 Thousand -158.09 Thousand -15.24 Thousand
Interest Expense - - - - - -
Income Tax Expense -14.97 Thousand 433.7 Thousand -8392.00 -60.2 Thousand -496.57 Thousand -3.00
Earnings before Tax -29.95 Thousand 426.06 Thousand -16.8 Thousand -120.64 Thousand -995.14 Thousand -15.24 Thousand
Net Income -14.97 Thousand 426.9 Thousand -8420.00 -60.44 Thousand -498.56 Thousand -15.24 Thousand
Earnings Per Share Basic -0.00 0.02 -0.00 -0.00 -0.03 -0.00
Earnings Per Share Diluted -0.00 0.02 -0.00 -0.00 -0.03 -0.00
Weighted Average Shares Outstanding 18.13 Million 18.13 Million 18.13 Million 16.63 Million 16.63 Million 15.24 Million
Weighted Average Shares Outstanding (Diluted) 18.13 Million 18.13 Million 18.13 Million 16.63 Million 16.63 Million 15.24 Million
Gross Margin - 0.62 0.57 1.00 0.74 1.00
EBIT Margin - 42.99 -7.55 -4.19 -15.42 -1.17
Profit Margin - 42.69 -3.77 -7.98 -48.91 -1.25
EBITDA -25 Thousand 429.86 Thousand -15.85 Thousand -119.69 Thousand -994.18 Thousand -14.29 Thousand
Earnings Before Tax Margin - -0.85 -7.97 -4.32 -15.51 -1.25

Income Statement Charts